These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21990984)

  • 41. [Experimental study of actin and myosin in the scar tissue].
    Zhang Q; Qian YL; Cui L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Jan; 15(1):32-5. PubMed ID: 12563927
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of apoptosis in keloids and a comparative study on apoptosis between keloids, hypertrophic scars, normal healed flat scars, and dermatofibroma.
    Akasaka Y; Fujita K; Ishikawa Y; Asuwa N; Inuzuka K; Ishihara M; Ito M; Masuda T; Akishima Y; Zhang L; Ito K; Ishii T
    Wound Repair Regen; 2001; 9(6):501-6. PubMed ID: 11896992
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Wide spread scars, hypertrophic scars, and keloids.
    Rudolph R
    Clin Plast Surg; 1987 Apr; 14(2):253-60. PubMed ID: 3581659
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreased expression of inhibitory SMAD6 and SMAD7 in keloid scarring.
    Yu H; Bock O; Bayat A; Ferguson MW; Mrowietz U
    J Plast Reconstr Aesthet Surg; 2006; 59(3):221-9. PubMed ID: 16676428
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differentiation of keloid and hypertrophic scar; correlation of the water proton relaxation times with the duration of the scar.
    Babu M; Bai RP; Suguna L; Ramachandran K; Ramakrishnan KM
    Physiol Chem Phys Med NMR; 1993; 25(2):113-20. PubMed ID: 8397424
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fas-mediated apoptotic signal transduction in keloid and hypertrophic scar.
    Lu F; Gao J; Ogawa R; Hyakusoku H; Ou C
    Plast Reconstr Surg; 2007 May; 119(6):1714-1721. PubMed ID: 17440345
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intralesional cryotherapy for enhancing the involution of hypertrophic scars and keloids.
    Har-Shai Y; Amar M; Sabo E
    Plast Reconstr Surg; 2003 May; 111(6):1841-52. PubMed ID: 12711943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fibrillin-1 and elastin are differentially expressed in hypertrophic scars and keloids.
    Amadeu TP; Braune AS; Porto LC; Desmoulière A; Costa AM
    Wound Repair Regen; 2004; 12(2):169-74. PubMed ID: 15086768
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heterogeneity of human fibroblasts isolated from hypertrophic scar.
    Ţuţuianu R; Roşca AM; Florea G; Prună V; Iacomi DM; Rădulescu LA; Neagu TP; Lascăr I; Titorencu ID
    Rom J Morphol Embryol; 2019; 60(3):793-802. PubMed ID: 31912089
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential apoptosis markers in human keloids and hypertrophic scars fibroblasts.
    De Felice B; Garbi C; Santoriello M; Santillo A; Wilson RR
    Mol Cell Biochem; 2009 Jul; 327(1-2):191-201. PubMed ID: 19224335
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of collagen gene expression in keloids and hypertrophic scars.
    Friedman DW; Boyd CD; Mackenzie JW; Norton P; Olson RM; Deak SB
    J Surg Res; 1993 Aug; 55(2):214-22. PubMed ID: 8412102
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dietary compounds inhibit proliferation and contraction of keloid and hypertrophic scar-derived fibroblasts in vitro: therapeutic implication for excessive scarring.
    Phan TT; Sun L; Bay BH; Chan SY; Lee ST
    J Trauma; 2003 Jun; 54(6):1212-24. PubMed ID: 12813346
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The distrubution of cell cycle on fibrolasts derived from the pathlogical scars and analysis of Fas gene mutations in keloids using polymerse chain Reaction-based single-strand conformation polymorphism].
    Lu F; Gao j ; Li X
    Zhonghua Yi Xue Za Zhi; 2000 Sep; 80(9):709-12. PubMed ID: 11798842
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Imaging of collagen deposition disorders using optical coherence tomography.
    Ring HC; Mogensen M; Hussain AA; Steadman N; Banzhaf C; Themstrup L; Jemec GB
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):890-8. PubMed ID: 25178655
    [TBL] [Abstract][Full Text] [Related]  

  • 55. mTOR as a potential therapeutic target for treatment of keloids and excessive scars.
    Ong CT; Khoo YT; Mukhopadhyay A; Do DV; Lim IJ; Aalami O; Phan TT
    Exp Dermatol; 2007 May; 16(5):394-404. PubMed ID: 17437482
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of hypertrophic scars and keloids with a radiofrequency device: a study of collagen effects.
    Meshkinpour A; Ghasri P; Pope K; Lyubovitsky JG; Risteli J; Krasieva TB; Kelly KM
    Lasers Surg Med; 2005 Dec; 37(5):343-9. PubMed ID: 16365887
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Expression and significance of alpha5beta1 integrin in abnormal scars].
    Yu Y; He GZ; Wu Y; Huang CB
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2004 Jul; 20(4):271-3. PubMed ID: 15568751
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of biomarkers involved in differential profiling of hypertrophic and keloid scars versus normal skin.
    Suarez E; Syed F; Alonso-Rasgado T; Bayat A
    Arch Dermatol Res; 2015 Mar; 307(2):115-33. PubMed ID: 25322916
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comparative characteristics of oxyproline excretion in urine in children with post-burn hypertrophic and keloid scars].
    Kozlov EA; Bagdatlishvili GI; Prozorovskaia NN; Del'vig AA
    Vopr Med Khim; 1991; 37(3):17-9. PubMed ID: 1949673
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proteoglycans of uterine fibroids and keloid scars: similarity in their proteoglycan composition.
    Carrino DA; Mesiano S; Barker NM; Hurd WW; Caplan AI
    Biochem J; 2012 Apr; 443(2):361-8. PubMed ID: 22257180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.